Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 25871 participants.

Also called NCT02271230

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 25,871 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02271230
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02271230. Randomized; quadruple masking; primary purpose prevention. Start 2014-08 (registry gives no type); primary completion 2019-12 (actual). Results posted on 2022-03-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure
Condition
Heart Failure
Intervention (Drug)
Vitamin D and fish oil
Intervention (Dietary supplement)
Fish oil (EPA/DHA) alone
Intervention (Drug)
Vitamin D alone
Intervention (Other)
Placebo
Lead sponsor
Brigham and Women's Hospital (class: other)

Record details

Record id
cardio:ct-nct02271230
Content hash
6cf7ea60b85d4b5272929d5deaa4077e0eae6499394ea3d1cb184b55e92936a6